M2428135
Etiracetam , ≥99% , 33996-58-6
Synonym(s):
(RS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide;1:1 mixture of levetiracetam S-enantiomer and levetiracetam R-enantiomer;2(RS)-(2-Oxopyrrolidin-1-yl)butyramide;Etiracetam
| Pack Size | Price | Stock | Quantity |
| 50mg | RMB719.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 113-114 °C(Solv: acetone (67-64-1)) |
| Boiling point: | 395.9±25.0 °C(Predicted) |
| Density | 1.168±0.06 g/cm3(Predicted) |
| vapor pressure | 0Pa at 25℃ |
| storage temp. | Store at -20°C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| pka | 15.74±0.50(Predicted) |
| form | Solid |
| color | White to off-white |
| Water Solubility | 401g/L at 20℃ |
| BRN | 1529106 |
| LogP | 0.7 at 20℃ |
Description and Uses
A nootropic drug that produced a significant increase in β-wave activity and stimulated α-wave activity dose-dependently. Etiracetam has been used in studies to alleviate the effects of memory retrieval defic its in rats.
Safety
| Symbol(GHS) |   GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302-H319-H411 |
| Precautionary statements | P264-P270-P273-P280-P301+P312-P305+P351+P338 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-36-51/53 |
| Safety Statements | 26-61 |
| RIDADR | UN 3077 9 / PGIII |
| HS Code | 2933790002 |
| Toxicity | mouse,LD50,intravenous,1790mg/kg (1790mg/kg),United States Patent Document. Vol. #4696943, |
